序号 |
标题 |
次数 |
作者 |
发布时间 |
84286 |
β-环糊精改性酰胺型聚羧酸减水剂 β-CD-MPC |
108 |
h |
2024-11-27 |
84287 |
DOTA-fCYwKTCT-CHO,204318-14-9 |
98 |
zcy |
2024-11-27 |
84288 |
聚多巴胺改性柠檬酸偶联β-环糊精-纳米银 CD-CA/PDA-xAg |
166 |
h |
2024-11-27 |
84289 |
DOTA-NKL , DOTA偶联肽D-K6L9修饰NGR |
96 |
kx |
2024-11-27 |
84290 |
4-硝氨基-N-(3-硝氨基-[1,2,4]三唑并[4,3-b][1,2,4,5]四嗪)1,2,5-噁二唑-3-胺 |
116 |
WYQ |
2024-11-27 |
84291 |
聚苯胺-β-环糊精包合物 PANI-β-CD |
131 |
h |
2024-11-27 |
84292 |
3-氨基-6-(3,5-二甲基吡唑)-1,2,4-三唑并[4,3-b][1,2,4,5]四嗪 |
127 |
WYQ |
2024-11-27 |
84293 |
4-硝氨基-N-(3-硝氨基-[1,2,4]三唑并[4,3-b][1,2,4,5]四嗪)1,2,5-噁二唑-3-氨二4-氨基-1,2,4-三唑盐 |
142 |
WYQ |
2024-11-27 |
84294 |
聚六亚甲基单胍接枝β-环糊精 PHMG-β-CD |
112 |
h |
2024-11-27 |
84295 |
4-硝氨基-N-(3-硝氨基-[1,2,4]三唑并[4,3-b][1,2,4,5]四嗪)1,2,5-噁二唑-3-氨二1,2,4-三唑盐 |
131 |
WYQ |
2024-11-27 |
84296 |
4-硝氨基-N-(3-硝氨基-[1,2,4]三唑并[4,3-b][1,2,4,5]四嗪)1,2,5-噁二唑-3-氨二羟胺盐 |
160 |
WYQ |
2024-11-27 |
84297 |
四嗪吡啶类配合物{[Cu(3-bptz)0.5(L-asp)]·1.5H2O}n(6) |
106 |
WYQ |
2024-11-27 |
84298 |
DOTA标记的c(RGDfK)环肽,DOTA-cyclo(RGDfK) |
108 |
zcy |
2024-11-27 |
84299 |
聚乙二醇-聚乳酸共聚物 MPEG-PLA4armPEG-PLA |
85 |
h |
2024-11-27 |
84300 |
四嗪吡啶类配合物{[Co(4-bptz)(btc)]·2H2O·DMF}n(5) |
147 |
WYQ |
2024-11-27 |
84301 |
四嗪吡啶类配合物{[Mn(4-bptz)(Hbtc)]·H2O·2DMF}n(4) |
75 |
WYQ |
2024-11-27 |
84302 |
DOTA-Ala-Ala-Tyr-COOH,DOTA-丙氨酸-丙氨酸-酪氨酸-羧酸 |
85 |
zcy |
2024-11-27 |
84303 |
4-硝氨基-N-(3-硝氨基-[1,2,4]三唑并[4,3-b][1,2,4,5]四嗪)1,2,5-噁二唑-3-氨二肼盐 |
111 |
WYQ |
2024-11-27 |
84304 |
DOTA-TMTP1 ,TMTP1偶联双功能螯合剂1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA) |
110 |
kx |
2024-11-27 |
84305 |
4-硝氨基-N-(3-硝氨基-[1,2,4]三唑并[4,3-b][1,2,4,5]四嗪)1,2,5-噁二唑-3-氨二铵盐 |
107 |
WYQ |
2024-11-27 |
84306 |
DOTA-TATE acetate,DOTA-3-酪氨酰基-奥曲肽醋酸盐 |
77 |
zcy |
2024-11-27 |
84307 |
4-硝氨基-N-(3-硝氨基-[1,2,4]三唑并[4,3-b][1,2,4,5]四嗪)1,2,5-噁二唑-3-氨二钠盐 |
141 |
WYQ |
2024-11-27 |
84308 |
p-NCS-Bz-DOTA-GA ,CAS:2125661-64-3 |
91 |
zyl |
2024-11-27 |
84309 |
荧光素FAM标记小分子多肽cNGQGEQc-L , FAM-cNGQGEQc-L , FAM-cNGQGEQc-C |
547 |
kx |
2024-11-27 |
84310 |
DOTA-Gd-Biotin |
88 |
zyl |
2024-11-27 |
84311 |
树枝状大孔二氧化硅纳米粒子(DLMSNs) |
112 |
kx |
2024-11-27 |
84312 |
3,6-二氨基-1,2,4,5-四嗪(DAT) |
184 |
WYQ |
2024-11-27 |
84313 |
环状肽909024-55-1,DOTA-cyclo(RGDfK) acetate |
118 |
zyl |
2024-11-27 |
84314 |
3-硝基胍-6-氨基-1,2,4,5-四嗪(NAT) |
113 |
WYQ |
2024-11-27 |
84315 |
DOTA-pHLIP ,双功能螯合剂DOTA偶联插膜肽pHLIP |
81 |
kx |
2024-11-27 |
84316 |
2,5-双-(3-氨基-4-硝胺基-1,2,4-三唑基)-吡嗪(BANTP) |
160 |
WYQ |
2024-11-27 |
84317 |
大环化合物DOTA-(COOt-Bu)3-NHFmoc-Lys |
83 |
zyl |
2024-11-27 |
84318 |
DOTA PEG3 N3,1428146-79-5 |
162 |
zcy |
2024-11-27 |
84319 |
七肽DOTA-VLASSAR,CAS号:1262403-90-6 |
93 |
zyl |
2024-11-27 |
84320 |
S-四嗪-BODIPY花菁荧光探针 |
100 |
WYQ |
2024-11-27 |
84321 |
DOTA-COOH 大环螯合物-羧基 |
111 |
zcy |
2024-11-27 |
84322 |
4,4′,6,6′-四(叠氮基)肼-1,3,5-三嗪(THAT)的银盐(Ag(THAT)) |
72 |
WYQ |
2024-11-27 |
84323 |
DOTA-ky-cNGR ,螯合剂DOTA标记环状ky-cNGR |
82 |
kx |
2024-11-27 |
84324 |
4,4′,6,6′-四(叠氮基)肼-1,3,5-三嗪(THAT)的铜盐(Cu(THAT)₂) |
115 |
WYQ |
2024-11-27 |
84325 |
DOTA-TATE,CAS:177943-89-4, DOTA-3-酪氨酰基-奥曲肽 |
104 |
zyl |
2024-11-27 |
84326 |
四嗪吡啶类配合物{[Zn(4-bptz)(Hbtc)]·H2O·DMF}n(3) |
147 |
WYQ |
2024-11-27 |
84327 |
Gd-Dota,CAS号:83678-67-5 |
97 |
zcy |
2024-11-27 |
84328 |
四嗪吡啶类配体3,6-二(3-吡啶基)-1,2,4,5-四嗪(3-bptz) |
174 |
WYQ |
2024-11-27 |
84329 |
3-硝基胍-6-(3,5-二甲基吡唑)-1,2,4,5-四嗪(NDT) |
108 |
WYQ |
2024-11-27 |
84330 |
NTz O(6-硝基-1,2,4,5-四嗪-3-酮) |
138 |
WYQ |
2024-11-27 |